Next week at Nanomed Europe 23, NTx will be well represented. Molly Stevens, NTx UK Board Member and Scientific Advisor, will deliver a keynote presentation on designing nanomaterials for therapeutics, and Arpan Desai, NTx UK Managing Director, will speak about how we’re using inspiration from biology to design a new generation of LNPs for enabling genetic medicines.